Harding Loevner’s LeMaitre Vascular LMAT Stock Holding History

Harding Loevner’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-192	Closed	-$10K	–	124
2022 Q3	$10K	Hold	192	–	–	﹤0.01%	156
2022 Q2	$9K	Hold	192	–	–	﹤0.01%	152
2022 Q1	$7K	Sell	192 -125	-39%	-$5.59K	﹤0.01%	153
2021 Q4	$16K	Hold	317	–	–	﹤0.01%	154
2021 Q3	$17K	Hold	317	–	–	﹤0.01%	141
2021 Q2	$19K	Hold	317	–	–	﹤0.01%	134
2021 Q1	$15K	Hold	317	–	–	﹤0.01%	146
2020 Q4	$13K	Hold	317	–	–	﹤0.01%	138
2020 Q3	$10K	Hold	317	–	–	﹤0.01%	173
2020 Q2	$8K	Hold	317	–	–	﹤0.01%	138
2020 Q1	$8K	Buy	317 +66	+26%	+$2.04K	﹤0.01%	139
2019 Q4	$9K	Buy	+251	New	+$8.66K	﹤0.01%	134

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.98B AUM 60.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Harding Loevner's LMAT Position: Q4 2022 in Review

Harding Loevner sold out of LeMaitre Vascular (LMAT) in Q4 2022, closing a stake of 192 shares — an estimated $10K sold.

Harding Loevner first reported a position in LMAT in Q4 2019 and held it in 12 quarters. The position peaked at $19K in Q2 2021. 181 funds tracked by Wall St. Rank hold LMAT as of Q4 2022.

Harding Loevner reported no remaining LeMaitre Vascular position as of Q4 2022 after selling out during the quarter.
Harding Loevner sold 192 LeMaitre Vascular shares in Q4 2022, an estimated $10K.
Harding Loevner first reported a position in LeMaitre Vascular in Q4 2019 and held it in 12 quarters.
Harding Loevner's LeMaitre Vascular position peaked at $19K in Q2 2021.
181 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2022.

Based on Harding Loevner's 13F filing for Q4 2022, filed 14 Feb 2023.